









Mercado
/
Acciones
/
nasdaq-lung
/

Pulmonx Corp

LUNG

1.650USD

+0.040+2.48%

Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min

67.23MCap. mercado

PérdidaP/E TTM



Pulmonx Corp

1.650

+0.040+2.48%

Descripción general Compañía Finanzas

Pulmonx Corporation is a commercial-stage medical technology company. The Company provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. Its solutions, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System) and the StratX Lung Analysis Platform (StratX Platform), is designed to treat severe emphysema patients. The StratX Platform is a cloud-based quantitative CT analysis service that offers physicians with a report that is designed for its solution, which includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation and has been validated in multiple randomized controlled clinical trials.

Información de la empresa

Símbolo de cotizaciónLUNG

Nombre de la empresaPulmonx Corp

Fecha de salida a bolsaOct 01, 2020

Director ejecutivoMr. Steven S. (Steve) Williamson

Número de empleados291

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 01

Dirección700 Chesapeake Dr

CiudadREDWOOD CITY

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal94063

Teléfono16509342600

Sitio Webhttps://pulmonx.com/

Símbolo de cotizaciónLUNG

Fecha de salida a bolsaOct 01, 2020

Director ejecutivoMr. Steven S. (Steve) Williamson

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Geoffrey Beran Rose

Chief Commercial Officer

237.06K

-2.85%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Steven S. (Steve) Williamson

President, Chief Executive Officer, Director

30.45K

-24.58%

Mr. Mehul Joshi

Chief Financial Officer

11.52K

-41.16%

Mr. Brian Johnston

Investor Relations

Mr. David A. Lehman

General Counsel

Ms. Georgia Garinoismelenikiotou

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Geoffrey Beran Rose

Chief Commercial Officer

237.06K

-2.85%

Mr. Daniel P. (Dan) Florin

Independent Director

102.02K

+145.58%

Mr. Richard M. (Rich) Ferrari

Independent Director

71.81K

+68.35%

Ms. Tiffany Sullivan

Independent Director

59.98K

+162.74%

Mr. Thomas William Burns

Independent Director

58.18K

+176.67%

Mr. Steven S. (Steve) Williamson

President, Chief Executive Officer, Director

30.45K

-24.58%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sin datos

Por regiónUSD

Nombre

Ganancia

Proporción

United States

14.22M

63.10%

Europe, Middle-East and Africa ("EMEA")

5.48M

24.33%

Asia Pacific

2.79M

12.40%

Other International

38.00K

0.17%

Por negocio

Por región

Sin datos

Estadísticas de accionistas

Actualizado: mié., 2 de jul

Accionistas

Tipos de accionistas

Accionistas

Proporción

PRIMECAP Management Company

13.45%

Fidelity Management & Research Company LLC

11.71%

Morgan Stanley & Co. LLC

7.27%

BlackRock Institutional Trust Company, N.A.

6.30%

The Vanguard Group, Inc.

5.67%

Other

55.60%

Accionistas

Proporción

PRIMECAP Management Company

13.45%

Fidelity Management & Research Company LLC

11.71%

Morgan Stanley & Co. LLC

7.27%

BlackRock Institutional Trust Company, N.A.

6.30%

The Vanguard Group, Inc.

5.67%

Other

55.60%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

51.20%

Hedge Fund

16.03%

Investment Advisor/Hedge Fund

14.74%

Research Firm

9.33%

Individual Investor

4.21%

Sovereign Wealth Fund

0.38%

Bank and Trust

0.19%

Pension Fund

0.05%

Insurance Company

0.03%

Other

3.85%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

286

39.72M

98.66%

-2.86M

2025Q1

296

39.33M

97.70%

-4.34M

2024Q4

300

39.10M

98.27%

-6.73M

2024Q3

306

39.39M

100.59%

-8.60M

2024Q2

305

38.59M

99.39%

-11.14M

2024Q1

300

38.64M

99.54%

-10.45M

2023Q4

294

37.11M

96.84%

-10.90M

2023Q3

296

35.84M

94.15%

-16.29M

2023Q2

300

36.45M

96.58%

-16.49M

2023Q1

313

37.10M

98.35%

-13.03M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

PRIMECAP Management Company

5.41M

13.45%

-97.53K

-1.77%

Mar 31, 2025

Fidelity Management & Research Company LLC

4.71M

11.71%

-443.86K

-8.61%

Mar 31, 2025

Morgan Stanley & Co. LLC

2.93M

7.27%

+396.76K

+15.68%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.54M

6.3%

-38.08K

-1.48%

Mar 31, 2025

The Vanguard Group, Inc.

2.28M

5.67%

-1.15K

-0.05%

Mar 31, 2025

Deerfield Management Company, L.P.

1.89M

4.69%

+355.24K

+23.15%

Mar 31, 2025

BNP Paribas Asset Management USA, Inc.

1.25M

3.11%

Mar 31, 2025

DWS Investments UK Limited

1.13M

2.81%

+31.06K

+2.82%

Mar 31, 2025

Silvercrest Asset Management Group LLC

930.56K

2.31%

+930.56K

Mar 31, 2025

Geode Capital Management, L.L.C.

927.54K

2.3%

+25.30K

+2.80%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 2 de ago

Nombre

Proporción

iShares Micro-Cap ETF

0.02%

iShares Russell 2000 Growth ETF

0.01%

Proshares Ultra Russell 2000

Avantis US Equity ETF

iShares Core S&P Total U.S. Stock Market ETF

Global X Russell 2000 ETF

Schwab U.S. Broad Market ETF

FlexShares Morningstar US Market Factor Tilt Index Fund

Goldman Sachs Innovate Equity ETF

SPDR S&P Health Care Equipment ETF

iShares Micro-Cap ETF

Proporción0.02%

iShares Russell 2000 Growth ETF

Proporción0.01%

Proshares Ultra Russell 2000

Proporción0%

Avantis US Equity ETF

Proporción0%

iShares Core S&P Total U.S. Stock Market ETF

Proporción0%

Global X Russell 2000 ETF

Proporción0%

Schwab U.S. Broad Market ETF

Proporción0%

FlexShares Morningstar US Market Factor Tilt Index Fund

Proporción0%

Goldman Sachs Innovate Equity ETF

Proporción0%

SPDR S&P Health Care Equipment ETF

Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

